Newsletter/Booklets 7th Jul 2023

Market Access Barriers in The Pharmaceutical Sector in India’s Key Export Destinations

Authors

Parthsarathi Jha Partner | New Delhi | Noida
Sanjay Notani Partner | Mumbai
Naghm Ghei Principal Associate | Delhi NCR
Harika Bakaraju Principal Associate | Mumbai
Divyashree Suri Senior Associate | Delhi NCR
Mitul Kaushal Consultant | Delhi NCR

Latest Thought Leadership

News & Media 26th Apr 2025

Dailyhunt’s parent VerSe’s group CFO resigns amid other exits in finance team

Read More
Alerts & Updates 25th Apr 2025

RBI’s Draft Directions on Securitisation of Stressed Assets, 2025 (Released on April 9, 2025)

Read More
Newsletter/Booklets 22nd Apr 2025

Competition Law & Policy Newsletter for Q1 of 2025

Read More
Alerts & Updates 22nd Apr 2025

Implementation of the Cape Town Convention in India: A Legal Framework for Protection and Enforcement of Security Interests in Aircraft

Read More

This report examines the regulatory environment of some of India’s key trading partners, with a view to identify existing and potential trade barriers in exporting pharmaceuticals in these markets.  This serves as a ready reckoner and comprehensive guide for the pharmaceutical industry.

Click here

Privacy Policy

As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Economic Laws Practice (ELP) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ELP or any of its members to solicit any work through this website.